CMT Asset Management’s Pfizer PFE Stock Holding History

CMT Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-38,418	Closed	-$1.21M	–	180
2017 Q1	$1.25M	Buy	+38,418	New	+$1.21M	0.11%	111
2016 Q4	–	Sell	-204,338	Closed	-$6.24M	–	196
2016 Q3	$6.57M	Buy	204,338 +134,247	+192%	+$4.49M	0.3%	81
2016 Q2	$2.34M	Sell	70,091 -36,337	-34%	-$1.16M	0.12%	120
2016 Q1	$2.99M	Buy	106,428 +49,512	+87%	+$1.41M	0.2%	99
2015 Q4	$1.74M	Buy	+56,916	New	+$1.79M	0.09%	140
2015 Q2	–	Sell	-10,410	Closed	-$339K	–	217
2015 Q1	$344K	Buy	+10,410	New	+$331K	0.03%	175
2014 Q2	–	Sell	-44,016	Closed	-$1.25M	–	152
2014 Q1	$1.34M	Buy	44,016 +27,020	+159%	+$806K	0.17%	55
2013 Q4	$494K	Buy	+16,996	New	+$495K	0.02%	138

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CMT Asset Management's PFE Position: Q2 2017 in Review

CMT Asset Management sold out of Pfizer (PFE) in Q2 2017, closing a stake of 38,418 shares — an estimated $1.21M sold.

CMT Asset Management first reported a position in PFE in Q4 2013 and held it in 8 quarters. The position peaked at $6.57M in Q3 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

CMT Asset Management reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
CMT Asset Management sold 38,418 Pfizer shares in Q2 2017, an estimated $1.21M.
CMT Asset Management first reported a position in Pfizer in Q4 2013 and held it in 8 quarters.
CMT Asset Management's Pfizer position peaked at $6.57M in Q3 2016.
2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on CMT Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.